Chemours' Earnings and Revenues Surpass Estimates in Q3

Zacks Nov 7 03:30

RBC Capital Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $25

Futu NewsNov 6 20:34 · Ratings

Chemours Is Maintained at Equal-Weight by Morgan Stanley

Dow JonesNov 5 21:31 · Ratings

Chemours Analyst Ratings

BenzingaNov 5 21:20 · Ratings

Express News | Chemours Co : Morgan Stanley Cuts Target Price to $25.00 From $30.00

BreakingsNov 5 19:13

Should You Investigate The Chemours Company (NYSE:CC) At US$20.58?

Yahoo FinanceNov 5 18:20